Welcome to our dedicated page for MetLife SEC filings (Ticker: MET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MetLife, Inc. (NYSE: MET) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-supported tools to help interpret them. MetLife is a global financial services company offering insurance, annuities, employee benefits and asset management, with operations in more than 40 markets and leading positions in the United States, Asia, Latin America, Europe and the Middle East.
Investors can review current reports on Form 8-K, where MetLife discloses material events such as earnings announcements, segment reorganizations, acquisitions, reinsurance transactions and dividend declarations. Recent 8-K filings describe the designation of MetLife Investment Management (MIM) as a reportable segment, the reclassification of MetLife Holdings, the acquisition of PineBridge Investments, and a variable annuity reinsurance transaction with Talcott Resolution Life Insurance Company. Other 8-Ks address preliminary variable investment income information, preferred stock matters, and the company’s response to an unsolicited mini-tender offer.
Through this page, users can also locate quarterly and annual reporting materials referenced in MetLife’s filings, such as earnings releases, Quarterly Financial Supplements, total assets under management fact sheets and historical results supplements. These documents provide detail on segment performance across Group Benefits, Retirement and Income Solutions, regional insurance operations and MetLife Investment Management, as well as information on variable investment income and capital management.
Stock Titan’s platform enhances these filings with AI-powered summaries that explain key terms, highlight important changes and help clarify how specific disclosures may relate to MetLife’s broader business. Users can quickly identify items related to dividends, capital structure, segment changes, asset management acquisitions and risk transfer transactions without reading every line of each filing.
MetLife, Inc. presents its annual report describing how it plans to grow under its four-year New Frontier strategy, focusing on group benefits, retirement platforms, asset management and international markets. The company reorganized into six segments and elevated MetLife Investment Management (MIM) to a reportable segment.
MetLife completed the acquisition of global asset manager PineBridge Investments to add scale and broaden investment products and distribution for institutional clients. The filing also details extensive U.S. and international insurance, capital and solvency regulation, climate and cybersecurity oversight, and data privacy rules that shape MetLife’s capital, product, and risk management decisions worldwide.
MetLife, Inc. declared a series of preferred stock dividends for first quarter 2026. The company approved a semi-annual dividend of $29.375 per share on its 5.875% fixed-to-floating rate preferred stock, Series D, and quarterly dividends of $351.5625 per share on Series E and $296.875 per share on Series F, with holders of the related depositary shares receiving $0.3515625 and $0.296875 per share, respectively. MetLife also declared a quarterly dividend of $0.31501229 per share on its floating rate preferred stock, Series A, subject to final confirmation that it has met specified financial tests. All these dividends are payable on March 16, 2026, to shareholders of record as of February 27, 2026.
MetLife, Inc. filed a Form 13F reporting holdings as a 13F Combination Report that lists 6 Form 13F information table entries with a total reported value of $12,153,950.
The filing is submitted on behalf of MetLife investment managers and is signed by John McCallion, EVP, CFO and Head of MetLife Investment Management.
MetLife, Inc. furnished its quarterly and full-year 2025 earnings materials and provided an updated multi-year outlook. The company reported $3.6 billion of cash and liquid assets at its holding companies as of December 31, 2025, which is within its $3.0 billion to $4.0 billion target range, and plans to maintain this target in 2026.
MetLife states it returned approximately $4.4 billion to shareholders in 2025 and remains on track to generate about $25.0 billion of free cash flow over 2025–2029. Assuming a 10-year U.S. Treasury rate of 4.40% at December 31, 2026, S&P 500 annual returns of 5% and private equity returns of 9% in 2026, it estimates $1.6 billion of pre-tax variable investment income for 2026 and expects its two-year average free cash flow to adjusted earnings ratio to stay at 65%–75%. The company is maintaining near-term annual targets for adjusted return on equity of 15%–17%, double-digit adjusted earnings per share growth, and direct expense ratio targets of 12.1% for 2026 and 11.3% in 2029, while indicating it does not expect material liquidity deficiencies or covenant issues.
MetLife (MET) filed a notice of proposed stock sales under Rule 144. The filing covers the potential sale of 562 shares of common stock through Bernstein Institutional Services LLC on the NYSE, with an aggregate market value of $44,836.36.
The shares to be sold were originally acquired on May 29, 2015 in a cash purchase from Goldman Sachs, with payment completed on June 3, 2015. The planned sale date is approximately January 9, 2026.
The notice also lists prior sales of MetLife common stock during the past three months by MetLife 401k Plan and several MetLife separate accounts, including blocks such as 359 shares sold on December 19, 2025 by MetLife 401k Plan Trust-Large Cap Equity Index for gross proceeds of $29,283.63.
MetLife, Inc. has reorganized its business structure to highlight growth in asset management. In the fourth quarter of 2025, the company made MetLife Investment Management (MIM), its institutional asset management unit, a separate reportable segment, while MetLife Holdings is no longer a reportable segment and is now mainly included in Corporate & Other. Certain products formerly in MetLife Holdings have been reclassified into Group Benefits and Retirement and Income Solutions (RIS).
Following these changes, MetLife is now organized into six segments: Group Benefits, RIS, Asia, Latin America, Europe, the Middle East and Africa, and MIM, with additional results in Corporate & Other. Effective January 1, 2025, MetLife also amended agreements between MIM and MetLife entities so that MIM manages general account assets at current market fee rates, compared with 2024 terms. The company states that these updates did not change prior period consolidated net income or consolidated adjusted earnings and has provided a Historical Results Financial Supplement to help investors compare past periods under the new structure.
The Vanguard Group reported its ownership of MetLife Inc. common stock as of 12/31/2025. Vanguard beneficially owned 72,555,322 MetLife shares, representing 11.01 % of the outstanding common stock. Vanguard reported no sole voting power, shared voting power over 3,509,125 shares, sole dispositive power over 66,835,767 shares, and shared dispositive power over 5,719,555 shares.
The filing states that Vanguard is an investment adviser and that the shares are held in the ordinary course of business, not for the purpose of changing or influencing control of MetLife. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends and sale proceeds from these securities, and no single other person has an interest in more than five percent of the class.
MetLife, Inc. filed a report showing a director acquired additional common stock as part of standard board compensation. On 01/02/2026, the director received 639 shares of MetLife common stock at a price of $80.32 per share, recorded as an acquisition. After this transaction, the director beneficially owned 8,064 shares held directly.
The company explains that non-management directors receive a portion of their retainer fees in MetLife common stock. In this case, the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, so the award reflects compensation rather than an open-market purchase.
MetLife, Inc. director reported receiving common stock as part of non-management director compensation on 01/02/2026. The filing shows an acquisition of 639 shares of MetLife common stock at $80.32 per share, bringing the director's directly held position to 45,415 shares. An additional 10 shares are reported as indirectly owned through the MetLife Policyholder Trust.
The company’s arrangements pay a portion of non-management director retainer fees in MetLife common stock, and the director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
MetLife, Inc. disclosed that one of its directors received 639 shares of MetLife common stock on 01/02/2026 as part of non‑management director compensation, at a reported price of $0 per share. After this grant, the director beneficially owned 18,080 shares of MetLife common stock in direct ownership. The company notes that its compensation arrangements pay a portion of non‑management director retainer fees in MetLife common stock rather than cash.